Navigation Links
Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
Date:5/21/2009

RAPID2 identifies relevant signatures for H1N1 virus in record time

PRINCETON, N.J., May 21 /PRNewswire-FirstCall/ -- Siemens Corporate Research (SCR), Inc. (www.usa.siemens.com/research) announced that it developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests. This system marries the power of information technology with today's improved genomic sequencing to quickly identify genomic signatures unique to the set of organisms to be detected. These signatures are the foundation for a new generation of molecular diagnostic tests for the rapid detection of healthcare-associated infections such as the potentially deadly Methicillin-Resistant Staphylococcus Aureus (MRSA).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Gayle Wittenberg, Program Manager at Siemens Corporate Research's Princeton, New Jersey-based research and development center, along with her Princeton and Erlangen, Germany colleagues, have been utilizing complex information technology models to focus on genetic targets that quickly identify pathogenic bacteria. "The advantage of our RAPID2 system is that it provides an efficient framework for quickly identifying new biomarkers based on the genomic sequence of a particular pathogen," says Dr. Wittenberg. "In the event of a pandemic, such as the recent H1N1 Flu outbreak, our system would enable a rapid response with the development of a strain-specific diagnostic test. This would help medical professionals manage an outbreak more effectively from the outset."

SCR used its new system recently to quickly discover a DNA barcode for detecting the H1N1 Flu after they received the genomic sequences of the virus isolated from infected patients from the National Institute of Health (NIH).

In addition to applications related to healthcare-associated infections and disease outbreaks, SCR's RAPID2 system is suited for use within the food and water industries where products are tested for microbial contamination, as well for discovering genetic targets for cancer diagnostics.

About Siemens Corporate Research

Siemens Corporate Research, Inc. (SCR), based in Princeton, New Jersey, USA, is one of several Siemens Corporate Technology research and development centers worldwide. Since it was founded in 1977, its employees have transformed research into practical, innovative solutions and services to support Siemens broad range of businesses. Launched in 1999 as an SCR subsidiary, Siemens Technology-To-Business Center (TTB) LLC, located in Berkeley, California, is chartered with discovering and launching emerging technologies into profitable businesses. SCR is an integral part of the Siemens family. With 428,000 employees in 190 countries, Siemens reported worldwide sales of $116.6 billion in fiscal 2008. For more information on SCR, visit www.usa.siemens.com/research.


'/>"/>
SOURCE Siemens
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Siemens Introduces New Standard of Care for Breast Ultrasound
2. Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
3. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
6. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
7. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
8. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
9. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016 ... bekannt, dass sie einen entscheidenden Meilenstein durch ... Ein Aufruf zum Handeln, um Patientenresultate  bei ... trägt zu Fortschritten im Verständnis der Hepatischen ... ein Bewusstsein für Hepatische Enzephalopathie in der ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... company, today announced data from the first cohort ... clinical trial (the OVATION Study) combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  In the first three ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 04, 2016 , ... Momsense, Inc. has developed ... patented technology, The Smart Breastfeeding Meter, is designed to monitor and measure a ... now available for purchase at Target.com . , Breastfeeding is a ...
(Date:5/4/2016)... ... 04, 2016 , ... Recognizing that lifestyle medicine is essential to health and ... tapped David Katz, MD, MPH, president of the American College of Lifestyle Medicine, as ... is especially gratifying,” said Katz. “There is so much opportunity to add years to ...
(Date:5/4/2016)... ... 2016 , ... Natalie Jill is a well respected lifestyle mentor ... the launch of her new book: Natalie Jill’s 7 Day Jump Start: Unprocess Your ... jump start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw cacao formula. ...
(Date:5/4/2016)... , ... May 04, 2016 , ... The preeminent surgical ... Janice Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and ... of breast cancer that occurs in the milk ducts, according to an interview ...
(Date:5/4/2016)... ... ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned for its use ... on stem cell injections. The seminar is scheduled for Wednesday, May 18, from 6-8 ... 110, Ventura, CA. There are only 10 seats available. , “The purpose of ...
Breaking Medicine News(10 mins):